Gene · 6334
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Cardioprotective Potential of Marine Venom and Toxins. | Toxins (Basel) | 2026 | 41745729 | PubTator, text mining | PubMed |
| Beyond Ion Channels: Emerging Roles of FGF12 in Cellular Regulation and Cancer Progression. | Cells | 2026 | 41744813 | PubTator, text mining | PubMed |
| SUDEP update 2026: recent advances in experimental and clinical research. | Curr Opin Neurol | 2026 | 41735792 | PubTator, text mining | PubMed |
| Toward precision medicine in SCN3A variants-associated encephalopathies and epilepsy: optimizing genetic diagnosis and molecular subregional effects. | Front Neurol | 2026 | 41725720 | PubTator, text mining | PubMed |
| Multiscale Integration of Acceleration and Jerk Sensing in the Vestibular System. | Audiol Res | 2026 | 41718338 | PubTator, text mining | PubMed |
| Real-World Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: Long-Term Efficacy, Safety, and Co-Medication Adjustment. | Eur J Neurol | 2026 | 41704210 | PubTator, text mining | PubMed |
| Expanding the Clinical Spectrum of SCN8A-Related Epileptic Encephalopathy: Additional Auditory Impairment, Atypical MRI Abnormalities and Putative Mitochondrial Involvement. | J Mol Neurosci | 2026 | 41678003 | PubTator, text mining | PubMed |
| Base editing rescues seizures and sudden death in a SCN8A mutation-associated developmental epileptic encephalopathy model. | J Clin Invest | 2026 | 41623181 | PubTator, text mining | PubMed |
| Neuroblastoma: Anti-Invasive Effects of Tetracaine In Vitro. | Basic Clin Pharmacol Toxicol | 2026 | 41622707 | PubTator, text mining | PubMed |
| The role of astrocytes in Alzheimer's disease: Pathophysiology, biomarkers, and therapeutic potential. | J Alzheimers Dis | 2026 | 41527736 | PubTator, text mining | PubMed |
| An Overview of Drug-Resistant Epilepsies Based on Advances in Genetics: A Cohort Study. | Neurol India | 2026 | 41510857 | PubTator, text mining | PubMed |
| Clinical and genetic analysis of epilepsy in children with SCN8A gene variants. | Seizure | 2026 | 41380541 | PubTator, text mining | PubMed |
| Diagnostic value of genetic testing, with focus on CACNA1A, in children with episodic neurologic disorders: a single-centre retrospective study. | Eur J Paediatr Neurol | 2026 | 41370964 | PubTator, text mining | PubMed |
| Clinical and Genetic Spectrum of SCN8A-Related Disorders: A Retrospective Study From the Gulf Region. | J Child Neurol | 2026 | 41325016 | PubTator, text mining | PubMed |
| Singapore blue arboreal tarantula peptide Lv1a preferentially targets NaV1.6 with new world-like pharmacological mechanism. | Biochem Pharmacol | 2026 | 41319925 | PubTator, text mining | PubMed |
| Scorpion polypeptide BmK IT2 alleviates epileptic seizures and neuronal pyroptosis by regulating sodium channel Nav1.6. | J Ethnopharmacol | 2026 | 41197923 | PubTator, text mining | PubMed |
| Precision medicine for sodium channelopathy-related autism and epilepsy. | Trends Mol Med | 2026 | 41162233 | PubTator, text mining | PubMed |
| Selecting effective antiseizure medications for early treatment of SCN8A-related epilepsy using a machine learning approach incorporating clinician and caregiver assessments. | Epilepsia | 2026 | 41034159 | PubTator, text mining | PubMed |
| Structure and function of voltage-gated sodium channel Nav1.6: Involvement in the pathological process of neural injury. | Neural Regen Res | 2026 | 41017705 | PubTator, text mining | PubMed |
| Voltage-gated sodium channels in the nervous system: Molecular physiology to therapeutic interventions. | Neural Regen Res | 2026 | 40808385 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6334/papers?page=3